XML 69 R42.htm IDEA: XBRL DOCUMENT v3.6.0.2
INTANGIBLE ASSETS AND GOODWILL (Tables)
 12 Months Ended
Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of components of finite-lived intangible assets
The major components of intangible assets as of December 31, 2016 and 2015 were as follows:
 
Weighted-
Average
Useful
Lives
(Years)
 
2016
 
2015
(in millions)
Gross
Carrying
Amount
 
Accumulated
Amortization,
Including
Impairments
 
Net
Carrying
Amount
 
Gross
Carrying
Amount
 
Accumulated
Amortization,
Including
Impairments
 
Net
Carrying
Amount
Finite-lived intangible assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
Product brands
8
 
$
20,725

 
$
(6,883
)
 
$
13,842

 
$
22,083

 
$
(5,236
)
 
$
16,847

Corporate brands
17
 
999

 
(146
)
 
853

 
1,066

 
(107
)
 
959

Product rights/patents
8
 
4,240

 
(2,118
)
 
2,122

 
4,340

 
(1,712
)
 
2,628

Partner relationships
3
 
152

 
(128
)
 
24

 
218

 
(171
)
 
47

Technology and other
4
 
252

 
(160
)
 
92

 
480

 
(186
)
 
294

Total finite-lived intangible assets
7
 
26,368

 
(9,435
)
 
16,933

 
28,187

 
(7,412
)
 
20,775

Indefinite-lived intangible assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
Acquired IPR&D
NA
 
253

 
—

 
253

 
610

 
—

 
610

B&L Trademark
NA
 
1,698

 
—

 
1,698

 
1,698

 
—

 
1,698

 
 
 
$
28,319

 
$
(9,435
)
 
$
18,884

 
$
30,495

 
$
(7,412
)
 
$
23,083
Schedule of components of indefinite-lived intangible assets
The major components of intangible assets as of December 31, 2016 and 2015 were as follows:
 
Weighted-
Average
Useful
Lives
(Years)
 
2016
 
2015
(in millions)
Gross
Carrying
Amount
 
Accumulated
Amortization,
Including
Impairments
 
Net
Carrying
Amount
 
Gross
Carrying
Amount
 
Accumulated
Amortization,
Including
Impairments
 
Net
Carrying
Amount
Finite-lived intangible assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
Product brands
8
 
$
20,725

 
$
(6,883
)
 
$
13,842

 
$
22,083

 
$
(5,236
)
 
$
16,847

Corporate brands
17
 
999

 
(146
)
 
853

 
1,066

 
(107
)
 
959

Product rights/patents
8
 
4,240

 
(2,118
)
 
2,122

 
4,340

 
(1,712
)
 
2,628

Partner relationships
3
 
152

 
(128
)
 
24

 
218

 
(171
)
 
47

Technology and other
4
 
252

 
(160
)
 
92

 
480

 
(186
)
 
294

Total finite-lived intangible assets
7
 
26,368

 
(9,435
)
 
16,933

 
28,187

 
(7,412
)
 
20,775

Indefinite-lived intangible assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
Acquired IPR&D
NA
 
253

 
—

 
253

 
610

 
—

 
610

B&L Trademark
NA
 
1,698

 
—

 
1,698

 
1,698

 
—

 
1,698

 
 
 
$
28,319

 
$
(9,435
)
 
$
18,884

 
$
30,495

 
$
(7,412
)
 
$
23,083
Schedule of estimated aggregate amortization expense for each of the five succeeding years
Estimated annual amortization of long-lived assets with finite lives for the five years ending December 31 and thereafter are as follows:
(in millions)
 
 
2017
 
$
2,509

2018
 
2,395

2019
 
2,176

2020
 
1,995

2021
 
1,900

Thereafter
 
5,958

Total
 
$
16,933
Schedule of changes in the carrying amount of goodwill
The changes in the carrying amount of goodwill for the years ended December 31, 2016 and 2015 were as follows:
(in millions)
 
Developed Markets
 
Emerging Markets
 
Bausch + Lomb/International
 
Branded Rx
 
U.S. Diversified Products
 
Total
Balance, December 31, 2014
 
$
7,130

 
$
2,231

 
$
—

 
$
—

 
$
—

 
$
9,361

Acquisitions (Note 3)
 
9,154

 
309

 
—

 
—

 
—

 
9,463

Measurement period adjustments to acquisition accounting and other adjustments (Note 3)
 
33

 
4

 
—

 
—

 
—

 
37

Foreign exchange and other
 
(176
)
 
(132
)
 
—

 
—

 
—

 
(308
)
Balance, December 31, 2015
 
16,141

 
2,412

 
—

 
—

 
—

 
18,553

Acquisitions
 
1

 
—

 
—

 
—

 
—

 
1

Divestiture of a portfolio of neurology medical device products (Note 4)
 
(36
)
 
—

 
—

 
—

 
—

 
(36
)
Goodwill related to Ruconest® reclassified to assets held for sale (Note 4)(1)
 
(37
)
 
—

 
—

 
—

 
—

 
(37
)
Foreign exchange and other
 
47

 
(12
)
 
—

 
—

 
—

 
35

Impairment to goodwill of the former U.S. reporting unit
 
(905
)
 
—

 
—

 
—

 
—

 
(905
)
Realignment of segment goodwill
 
(15,211
)
 
(2,400
)
 
6,708

 
7,873

 
3,030

 
—

Impairment to goodwill of the Salix reporting unit
 
—

 
—

 
—

 
(172
)
 
—

 
(172
)
Divestitures (Note 4)
 
 
 
 
 
(5
)
 
—

 
 
 
(5
)
Goodwill of certain businesses reclassified to assets held for sale
 
—

 
—

 
(947
)
 
(431
)
 
—

 
(1,378
)
Foreign exchange and other
 
—

 
—

 
(257
)
 
(5
)
 
—

 
(262
)
Balance, December 31, 2016
 
$
—

 
$
—

 
$
5,499

 
$
7,265

 
$
3,030

 
$
15,794

____________________________________
(1)
Ruconest® was subsequently divested in the fourth quarter of 2016.